Key points are not available for this paper at this time.
Sodium-glucose cotransporter 2 (SGLT-2) inhibitors improve outcomes in patients with type 2 diabetes, heart failure, and chronic kidney disease, but their effect on outcomes of critically ill patients with organ failure is unknown.
Building similarity graph...
Analyzing shared references across papers
Loading...
Caio A.M. Tavares
Luciano César Pontes Azevedo
Álvaro Réa-Neto
JAMA
Imperial College London
University of Alberta
Monash University
Building similarity graph...
Analyzing shared references across papers
Loading...
Tavares et al. (Fri,) studied this question.
www.synapsesocial.com/papers/68e64a0ab6db6435875db466 — DOI: https://doi.org/10.1001/jama.2024.10510
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: